2248: Identification of a Novel Juvenile Myoclonic Epilepsy Gene and Its Underlying Disease Mechanism
Grant Status: Closed
AbstractEpilepsy is the most common neurological disease in dogs and affects almost all breeds. Genetics is likely to play a major role in seizure risk, and gene discovery remains as an important goal to better understand the disease and its treatment. However, genetic breakthroughs have been rare partially due to incomplete clinical diagnostics to identify true cases and controls, or to distinguish specific syndromes for genetic analyses. We have recently utilized an advanced wireless video-EEG approach in clinical studies to identify juvenile myoclonic epilepsy (JME) in Rhodesian Ridgebacks with characteristic epilepsy phenotype, age of onset and photosensitivity. The pedigree established using the JME cases suggests a strong genetic contribution and is supported by our preliminary genetic data that proposes a novel disease locus and a deleterious mutation in a neuronal candidate gene. These promising early findings necessitate further electroclinical and genetic studies for confirmation. In this study, the investigators’ objectives are to: i) further characterize EEG, imaging and disease features of JME, ii) confirm the presence and segregation of an epilepsy gene, iii) investigate the breed-specificity, prevalence and penetrance of the mutation, iv) conclude the inheritance model, and v) define the pathogenicity of the mutation. The confirmation of the genetic defect would allow us not only to develop a genetic test for breeding purposes but also to understand how myoclonic seizures develop. This could ultimately lead to improved treatments for canine epilepsy.
Wielaender, F., Sarviaho, R., James, F., Hytönen, M. K., Cortez, M. A., Kluger, G., … Lohi, H. (2017). Generalized myoclonic epilepsy with photosensitivity in juvenile dogs caused by a defective DIRAS family GTPase 1. Proceedings of the National Academy of Sciences.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.